Disease / condition
Breast Neoplasms clinical trials
Free access to 450 studies10+ countriesUpdated daily64 recruiting
VerifiedClinicalTrials.gov · WHO ICTRP · regional registries
450
Total trials
10+
Countries
10+
Sponsors
64
Recruiting
By phase
N/A206
Phase 2119
Phase 349
Phase 127
Early Phase 123
By status
Completed231
Recruiting64
Terminated44
Unknown43
Not yet recruit...27
Top countries
United States of America95
China59
South Korea32
Canada24
France17
Top sponsors
Pfizer39
Washington Univers...18
Boehringer Ingelhe...11
National Cancer In...10
Eli Lilly and Comp...10
Recent trials
Latest clinical trials for Breast Neoplasms
Effect of Preoperative Exercise on the Prevention of Secondary Lymphedema in Breast Cancer Patients
Asan Medical Center
NCT06421285Not yet recr...
Effect of Complex Decongestive Therapy, Cryotherapy and Kinesio Taping in Patients With Post-mastectomy Lymphedema: A Randomized Control Trial
South Valley University · Egypt
NCT06327438Recruiting
Minimal Access Versus Conventional Latissimus Dorsi Flap Harvest for Breast Reconstruction
Sun Yat-Sen Memorial Hospital ... · China
NCT06319157Recruiting
The Intestinal Microbiome in Triple Negative Breast Cancer Treated With Immunotherapy
Pennington Biomedical Research... · United States of America
NCT06318507Recruiting
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
Merck Sharp & Dohme LLC · Israel,Taiwan,United States of America
NCT06312176Recruiting
- Phase
- Phase 3
Study Of Capecitabine Combined With Camrelizumab For Non-pCR TNBC With TLS After Neoadjuvant Chemoterapy
Sun Yat-Sen Memorial Hospital ... · China
NCT06313463Recruiting
- Phase
- Phase 3
A Clinical Study of Darcilil Combined With AI Combined With Pyrrotinib in the Treatment of TPBC
Second Affiliated Hospital of ... · China
NCT06235931Recruiting
A Study on BReast Cancer Patient Care Using chAtbot and Video Education for Radiation Therapy (BRAVE)
Yonsei University · South Korea
NCT06207474Completed
The Efficacy and Safety of Lenvatinib Combined With Sindilimab and Nab-paclitaxel in the First-line Treatment for Recurrent and Metastatic Triple Negative Breast Cancer: a Phase Ib/IIa Clinical Trial.
Zhejiang Cancer Hospital · China
NCT06140576Not yet recr...
- Phase
- Phase 1/2
Phase I Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes for Advanced HER2-Negative Breast Cancer
Sun Yat-Sen Memorial Hospital ... · China
NCT06121557Recruiting
- Phase
- Phase 1
Phase I Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes as Neoadjuvant Therapy for HER2-Negative Breast Cancer
Sun Yat-Sen Memorial Hospital ... · China
NCT06121570Recruiting
- Phase
- Phase 1
Study of Disitamab Vedotin With Toripalimab Verus Disitamab Vedotin in Hormone Receptor Positive, HER2-low Locally Advanced or Metastatic Breast Cancer
RemeGen Co., Ltd. · China
NCT06105008Not yet recr...
- Phase
- Phase 2
Early Detection of Breast Cancer
Datar Cancer Genetics Inc · United States of America
NCT06043661Recruiting
Trilaciclib in Patients With Early-Stage HR-negative Breast Cancer Receiving Adjuvant Chemotherapy
wang shusen · China
NCT05978648Not yet recr...
- Phase
- Phase 2
Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes for Advanced HER2-Negative Breast Cancer
Sun Yat-Sen Memorial Hospital ... · China
NCT05981001Recruiting
- Phase
- Phase 1/2
Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes as Neoadjuvant Therapy for HER2-Negative Breast Cancer
Sun Yat-Sen Memorial Hospital ... · China
NCT05981014Recruiting
- Phase
- Phase 1/2
Evaluation of Vaginal Microbiome as a Biomarker for the Improvement of Vaginal Health in Women With Breast Cancer, ARISE Study
Ohio State University Comprehe... · United States of America
NCT05946668Recruiting
Untitled Trial
Eli Lilly Japan K.K. · Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Czech;Finland;France;Germany;Greece;China;Hu
jRCT2031230109Recruiting
Reducing Neutropenia Incidence With Pegfilgrastim Administration on Day 3 After Chemotherapy
Eunseong Medical Foundation Go... · South Korea
NCT05949333Not yet recr...
- Phase
- Phase 4
Prediction of Axillary Lymph Node Metastasis Status in Breast Cancer Based on PET/CT Radiomics
First Affiliated Hospital Xi'a...
NCT05826197Not yet recr...
About this profile
Access comprehensive clinical trial information for Breast Neoplasms through Pure Global AI's free database. This collection includes 450 clinical trials across multiple phases including N/A, Phase 2, Phase 3. Currently, 64 trials are actively recruiting participants.
Research for Breast Neoplasms is being conducted in United States of America, China, South Korea and 7+ other countries. Leading sponsors include Pfizer and Washington University School of Medicine. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.
Pure Global AI provides free access to 450 clinical trials studying Breast Neoplasms, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.
The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.
Top research sponsors include Pfizer, Washington University School of Medicine, Boehringer Ingelheim, among others.